文献速递临床生化临床免疫质量管理与危急值

LC-MS/MS 在临床化学中是否兑现了承诺:荷兰 EQAS 组织的思考

LC-MS/MS in clinical chemistry: Did it live up to its promise?: Consideration from the Dutch EQAS organisation.
PubMed 文献 · Clin Chim Acta · 2023-05-15

该研究基于荷兰 SKML 的 EQAS 结果,分析 2020 至 2021 年上半年 9 次调查中血清皮质醇、睾酮、25OH-维生素 D 及尿和唾液皮质醇的数据。发现 11 年间 LC-MS/MS 检测化合物和结果数量显著增加,2021 年约 4000 个结果而 2010 年仅 34 个。LC-MS/MS 方法在部分分析物上的实验室间 CV 与免疫分析法相当或更高,但偏倚和不精密度优于免疫分析法。

要点

  • LC-MS/MS 检测数量 11 年间大幅增长,2021 年约 4000 个结果。
  • 部分分析物 LC-MS/MS 实验室间 CV 与免疫法相当或更高。
  • LC-MS/MS 的偏倚和不精密度优于免疫分析法。

核心结论

  • 尽管预期 LC-MS/MS 因相对不受基质影响且更易标准化而能减小实验室间差异,但 SKML 轮转结果对某些分析物并未反映这一点,部分原因可能是多数情况下使用了实验室自建方法。

研究设计与样本

  • 研究分析了荷兰 SKML 的 EQAS 结果,覆盖血清皮质醇、睾酮、25OH-维生素 D 以及尿和唾液皮质醇,共 9 次调查(2020 年至 2021 年上半年)。

主要发现

  • 11 年间 LC-MS/MS 检测的化合物数量和不同基质中的结果数量显著增加,2021 年约 4000 个 LC-MS/MS 结果(血清:尿:唾液 = 58:31:11%),而 2010 年仅 34 个。
  • 与各免疫分析法相比,LC-MS/MS 方法对血清皮质醇、睾酮和 25OH-维生素 D 在不同调查样本中显示相当或更高的实验室间 CV。
  • LC-MS/MS 对皮质醇、睾酮和 25OH-维生素 D 的中位 CV 分别为 6.8%、6.1% 和 4.7%,免疫分析法分别为 3.9-8.0%、4.5-6.7% 和 7.5-18.3%。
  • LC-MS/MS 的偏倚和不精密度优于免疫分析法。

局限性

  • 多数情况下使用实验室自建方法,可能部分解释 LC-MS/MS 实验室间差异未如预期减小的现象。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Over the past decade the use of LC-MS/MS has increased significantly in the hospital laboratories. Clinical laboratories have switched from immunoassays to LC-MS/MS methods due to the promise of improvements in sensitivity and specificity, better standardization with often non-commutable international standards, and better between-laboratory comparison. However, it remains unclear whether routine performance of the LC-MS/MS methods have met these expectations. METHOD: This study examined the EQAS results, from the Dutch SKML, of serum cortisol, testosterone, 25OH-vitaminD and cortisol in urine and saliva over 9 surveys (2020 to first half of 2021). RESULTS: The study found a significant increase in the number of compounds and in the number of results measured in the different matrices, with LC-MS/MS over a period of eleven years. In 2021, approximately 4000 LC-MS/MS results were submitted (serum: urine: saliva = 58:31:11%) compared to only 34 in 2010. When compared to the individual immunoassays, the LC-MS/MS based methods for serum cortisol, testosterone and 25OH-vitaminD showed comparable but also higher between-laboratory CVs in different samples of the surveys. For cortisol, testosterone and 25OH-vitaminD the median CV was 6.8%, 6.1% and 4.7% respectively for the LC-MS/MS compared to 3.9-8.0%,4.5-6.7%, and 7.5-18.3% for immunoassays. However, the bias and imprecision of the LC-MS/MS was better than that of the immunoassays. CONCLUSION: Despite the expectation that LC-MS/MS methods would result in smaller between-laboratory differences, as they are relatively matrix independent and better to standardize, the results of the SKML round robins do not reflect this for some analytes and may be in part explained by the fact that in most cases laboratory developed tests were used.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Lentjes EGWM, Bui HN, Ruhaak LR, et al. LC-MS/MS in clinical chemistry: Did it live up to its promise?: Consideration from the Dutch EQAS organisation. Clin Chim Acta. 2023. PMID: 37196897. doi:10.1016/j.cca.2023.117391

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。